FII Holdings

JAGSONPAL PHARMACEUTICALS LTD.

NSE : JAGSNPHARMBSE : 507789ISIN CODE : INE048B01027Industry : Pharmaceuticals & DrugsHouse : Jagsonpal
BSE280.500.1 (+0.04 %)
PREV CLOSE ( ) 280.40
OPEN PRICE ( ) 279.70
BID PRICE (QTY) 279.50 (350)
OFFER PRICE (QTY) 281.00 (80)
VOLUME 1002
TODAY'S LOW / HIGH ( )279.15 282.65
52 WK LOW / HIGH ( )270.05 513.9
NSE280.20-0.5 (-0.18 %)
PREV CLOSE( ) 280.70
OPEN PRICE ( ) 284.90
BID PRICE (QTY) 280.00 (1287)
OFFER PRICE (QTY) 280.40 (10)
VOLUME 15708
TODAY'S LOW / HIGH( ) 279.00 284.90
52 WK LOW / HIGH ( )273.6 514.85
upfii downfii 
Current Quarter
Prev Quarter
Company Quarter Ended 202312 % of Share Quarter Ended 202309 % of Share Changeupfii

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.